IGHE and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, compared to the basic clinical model, the inclusion IgE or CML showed significant improvements in reclassification as assessed by categorical NRI (0.120 (0.047–0.194); 0.099 (0.034–0.163), respectively) and IDI (0.074 (0.049–0.010); 0.062 (0.038–0.086), respectively; Table 4).